Evaluation of a Couple-Based Physical Activity Intervention
Mates in Motion: Feasibility and Acceptability of a Couple-Based Physical Activity Intervention
3 other identifiers
interventional
96
1 country
1
Brief Summary
This clinical trial tests how well a couple-based physical activity (PA) intervention, Mates in Motion, works in patients undergoing hematopoietic cell transplantation (HCT) or chimeric antigen receptor T-cell therapy (CART) and their care giving partners to be more physically active. Mates in Motion provides training in communication skills and behavior change techniques to help HCT patient-caregiver dyads support one another in adoption and maintenance of PA. This study may help researchers determine if a couple-based PA intervention improves PA, physical endurance and global physical health among patient-care giver dyads undergoing HCT or CART.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2023
CompletedFirst Posted
Study publicly available on registry
October 10, 2023
CompletedStudy Start
First participant enrolled
March 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 3, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 3, 2025
CompletedSeptember 24, 2025
September 1, 2025
1.5 years
October 2, 2023
September 22, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
Observed recruitment
Will be assessed by the percentage of eligible patient-partner couples agreeing to participate
At baseline
Intervention adherence
Will be assessed by the number of intervention sessions attended.
8 weeks
Actigraph wear adherence
Will be assessed by the number of valid wear days.
8 weeks
Garmin wear adherence
Will be assessed by the number of valid wear days.
8 weeks
Retention
Will be assessed by the number of post-intervention follow-up assessments completed.
At 100 days post-hematopoietic cell transplant (HCT)
Secondary Outcomes (1)
Acceptability of the intervention
At 100 days post-hematopoietic cell transplant (HCT)
Study Arms (2)
Arm I (Mates in Motion)
EXPERIMENTALDyads participate in the Mates in Motion program consisting of weekly sessions to train couples in the use of communal coping strategies to support one another in achieving PA goals and skill building focus on instruction and practice in effective communication, with emphases on adaptive speaking, responsive listening, and joint decision-making and problem-solving around PA over 8 weeks. Patient-partner dyads receive weekly step-count goals, complete walk-tests and questionnaires and wear an Actigraph device and Garmin activity tracker on study.
Arm II (usual care)
ACTIVE COMPARATORPatient-partner dyads wear an Actigraph device, compete walk-tests and questionnaires on study. Dyads receive usual care on study. Dyads receive a Garmin activity tracker at the end of the study.
Interventions
Receive usual care
Undergo walk-test
Eligibility Criteria
You may qualify if:
- PATIENTS: Age 18 years or older
- PATIENTS: Scheduled to receive an autologous or allogeneic hematopoietic cell transplant (HCT) or chimeric antigen receptor (CAR)-T cell therapy
- PATIENTS: Able to speak and comprehend English
- PATIENTS: Being married or in a committed (self-defined) cohabiting same- or opposite-sex relationship
- PATIENTS: Physician-approved for a walking program
- CAREGIVERS: Age 18 years or older
- CAREGIVERS: Able to speak and comprehend English
- CAREGIVERS: Married to or in a committed, cohabiting, same- or opposite-sex relationship with the patient
- CAREGIVERS: Able to participate in a walking program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nandita Khera, MD, MPH
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 2, 2023
First Posted
October 10, 2023
Study Start
March 11, 2024
Primary Completion
September 3, 2025
Study Completion
September 3, 2025
Last Updated
September 24, 2025
Record last verified: 2025-09